Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Aura Biosciences granted inducement equity awards to three newly appointed C-level executives: Chief Regulatory and Quality Officer Dr. Erica Kratz, Chief Operating Officer Dr. Susan Abu-Absi, and Chief People Officer Julie Person. The awards consist of options to purchase an aggregate of 676,991 shares and restricted stock units for 343,009 shares, with an exercise price of $7.43 per share matching the September 1 closing price.
Key figures
- Exercise price
- 7.43
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.